C12N 2310/3233
Morpholino-type ring
C12N2310/3233 (Morpholino-type ring) appears on 567 US grants and 1,068 published applications in this corpus.
Search patents in C12N- Granted patents
- 567
- Published applications
- 1,068
- Assignees
- 304
- Inventors
- 1,146
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 4 | 2 |
| 2002 | 2 | 2 |
| 2003 | 2 | 15 |
| 2004 | 5 | 9 |
| 2005 | 3 | 17 |
| 2006 | 4 | 13 |
| 2007 | 1 | 15 |
| 2008 | 3 | 11 |
| 2009 | 6 | 14 |
| 2010 | 8 | 16 |
| 2011 | 9 | 27 |
| 2012 | 10 | 34 |
| 2013 | 24 | 24 |
| 2014 | 18 | 59 |
| 2015 | 26 | 59 |
| 2016 | 54 | 63 |
| 2017 | 33 | 61 |
| 2018 | 49 | 63 |
| 2019 | 44 | 72 |
| 2020 | 38 | 55 |
| 2021 | 64 | 90 |
| 2022 | 36 | 74 |
| 2023 | 29 | 69 |
| 2024 | 38 | 70 |
| 2025 | 34 | 91 |
| 2026 | 23 | 43 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions for delivery of antisense compounds22 Sep 2026US 12,741,989 B2Entrada Therapeutics, Inc.
- Compositions and methods for suppressing intracellular synthesis of the beta subunit of human chorionic gonadotropin1 Sep 2026US 12,721,896 B1
- Antisense molecules and methods for treating pathologies18 Aug 2026US 12,709,749 B2The University of Western Australia
- Cell-penetrating peptide conjugates and methods of their use7 Jul 2026US 12,673,108 B2Oxford University Innovation Limited
- Compositions and methods for treatment of kidney disease7 Jul 2026US 12,674,162 B2PYC Therapeutics Limited
- Methods of minimising effects of smoke exposure8 Oct 2026US 2026/0308597 A1Rage Biotech Pty Ltd
- Artificial amino acid containing lipo-oligomers for ribonucleoprotein delivery1 Oct 2026US 2026/0295075 A1Ludwig-Maximilians-Universitat Munchen
- Nucleic Acid Antisense Oligomer Readthrough of Nonsense Codons1 Oct 2026US 2026/0297572 A1University of Massachusetts
- Sirna molecule for regulating pcsk9 gene activity1 Oct 2026US 2026/0297585 A1Rona Bioscience, Limited
- Administration of oligonucleotides24 Sep 2026US 2026/0286366 A1Rage Biotech Pty Ltd
Most cited
By later US patents
- Alteration of cellular behavior by antisense modulation of mRNA processing259US 6,210,892 B1Isis Pharmaceuticals, Inc. · 2001
- Antisense modulation of BCL-X expression218US 6,172,216 B2Isis Pharmaceuticals, Inc. · 2001
- Compositions and methods for inhibiting expression of Eg5 gene215US 7,718,629 B2Alnylam Pharmaceuticals, Inc. · 2010
- Antisense antibacterial method and composition143US 6,677,153 B2AVI BioPharma, Inc. · 2004
- Antisense oligonucleotides for inducing exon skipping and methods of use thereof143US 7,960,541 B2The University of Western Australia · 2011